microdosing glp-1 menopause for GLP-1s for Menopause-Related Weight Gain A New Study Says That

Ozempic is FDA-approved for diabetes, not obesity, so Medicaid covers it when prescribed for blood sugar management

Christian Wber: has received honoraria consultancy/speaking from Apomedica, Curelator, Eli Lilly, Grnenthal, Hermes, Lundbeck, Novartis, Pfizer, Ratiopharm/Teva, and Stada

Quercetin and its glycosides A polar auxin transport inhibitor, quercetin is a flavonoid present in many plant foods including fruits, leaves, cereals, and vegetables

More body fat means more baseline inflammation, which means a lower threshold for disease activation

While liraglutide may not outperform newer GLP-1 options in efficacy, it offers a cost-effective alternative with proven benefits for both conditions

MR: Writing original draft, Methodology, Investigation, Supervision